abstract |
The present invention provides improved therapeutic agents and methods of treatment for the treatment of diseases associated with amyloid deposits of A [beta] in the patient's brain. The method comprises administering an agent that induces an amyloid deposit deposit beneficial immunogenic response. The method is useful for the prevention and treatment of Alzheimer's disease. A formulation comprising an N-terminal fragment of A [beta] and an antibody binding thereto is preferred. |